Isnain, Sitti Farrah S.

HRN: 28-53-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/12/2026
07/19/2026
PO
2.5 ML
TID
INTESTINAL AMOEBIASIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines